AU2677299A - Use of hyaluronidase to reduce viscoelastic related increases in intraocular pressure - Google Patents

Use of hyaluronidase to reduce viscoelastic related increases in intraocular pressure

Info

Publication number
AU2677299A
AU2677299A AU26772/99A AU2677299A AU2677299A AU 2677299 A AU2677299 A AU 2677299A AU 26772/99 A AU26772/99 A AU 26772/99A AU 2677299 A AU2677299 A AU 2677299A AU 2677299 A AU2677299 A AU 2677299A
Authority
AU
Australia
Prior art keywords
hyaluronidase
intraocular pressure
related increases
viscoelastic
reduce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26772/99A
Inventor
Mark B. Abelson
Jonathan M. Freilich
Mark Harooni
Miguel F. Refojo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schepens Eye Research Institute Inc
Original Assignee
Schepens Eye Research Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schepens Eye Research Institute Inc filed Critical Schepens Eye Research Institute Inc
Publication of AU2677299A publication Critical patent/AU2677299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
AU26772/99A 1998-02-17 1999-02-12 Use of hyaluronidase to reduce viscoelastic related increases in intraocular pressure Abandoned AU2677299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7483798P 1998-02-17 1998-02-17
US60074837 1998-02-17
PCT/US1999/003125 WO1999040933A1 (en) 1998-02-17 1999-02-12 Use of hyaluronidase to reduce viscoelastic related increases in intraocular pressure

Publications (1)

Publication Number Publication Date
AU2677299A true AU2677299A (en) 1999-08-30

Family

ID=22121967

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26772/99A Abandoned AU2677299A (en) 1998-02-17 1999-02-12 Use of hyaluronidase to reduce viscoelastic related increases in intraocular pressure

Country Status (2)

Country Link
AU (1) AU2677299A (en)
WO (1) WO1999040933A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000056354A2 (en) * 1999-03-22 2000-09-28 Boston Innovative Optics, Inc. Methods of using agents that act on the epithelial sheet of a human eye
US6969514B2 (en) * 2003-02-05 2005-11-29 Soll David B Method for treating elevated intraocular pressure, including glaucoma
MXPA03011987A (en) 2003-12-19 2005-06-23 Osio Sancho Alberto Method for treating presbyopia by inducing changes in the corneal power and physiology.
US8802651B2 (en) 2004-06-30 2014-08-12 Abbott Medical Optics Inc. Hyaluronic acid in the enhancement of lens regeneration
US20060083732A1 (en) * 2004-06-30 2006-04-20 Arlene Gwon Hyaluronic acid in the enhancement of lens regeneration
US7794697B2 (en) 2004-06-30 2010-09-14 Abbott Medical Optics Inc. Enhancement of lens regeneration using materials comprising polysiloxane polymers
CN104823100B (en) 2012-08-10 2020-04-24 奥西奥公司以约利亚健康公司名义经营 Contact lenses and methods of determining the fit of a contact lens for an eye of an individual

Also Published As

Publication number Publication date
WO1999040933A1 (en) 1999-08-19

Similar Documents

Publication Publication Date Title
AU5274000A (en) Prevention of regression in refractive keratoplasty
AU7648698A (en) Heterocyclic derivatives and their use as antithrombotic agents
AU2840701A (en) Caching of objects in disk-based databases
AU5722796A (en) Cyclobutane derivatives and their use as inhibitors of prote in farnesyltransferase
AU9681498A (en) Chromophores in the preparation of novel tandem conjugates
AU2033701A (en) Control of compressed mode transmission in wcdma
AU3542197A (en) Starch-containing cosmetic and cleaning compositions
EP0796914A3 (en) Alcohol dehydrogenase and its use in the enzymatic production of chiral hydroxy-compounds
AU2069995A (en) Enzymatic preparation of polysaccharides
AU2001276440A1 (en) Use and cosmetic compositions of starch betainates
AU7358800A (en) Compositions and methods for modification of skin lipid content
AU2001291051A1 (en) Bleached bran and bran products and methods of preparation
AU2001284135A1 (en) Use of tyramine in cosmetic compositions to lighten the skin
AU2677299A (en) Use of hyaluronidase to reduce viscoelastic related increases in intraocular pressure
AU3457697A (en) Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition
AU7245996A (en) Substantially pure apraclonidine and its use in lowering intraocular pressure
AU2462499A (en) Treatments to improve yields in the wet milling of corn
AU4455201A (en) Hyaluronidase activity and allergenic cell activity inhibitor
PL331098A1 (en) Intraocular pressure reducing compositions
AU2001281950A1 (en) Regulation of human thimet oligopeptidase-like enzyme
AU2001231287A1 (en) Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of the 5-ht7 receptor
AU2924800A (en) Use of glutathione-s-transferase to increase stress tolerance in plants
AU2001274080A1 (en) Regulation of human transketolase-like enzyme
AU7926298A (en) Improvements in and relating to cavity closers
AU2175500A (en) Improved viscoelastic compositions and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase